Nov 22, 2023
The Wolfpack Investor Network (“WIN”) is North Carolina State University’s angel investor group that provides capital and guidance to NC State connected, early-stage companies. WIN has just announced the completion of a follow-on round of financing for Natrx Inc., a Raleigh based company that uses a proprietary, advanced technology and manufacturing approach to deliver high-performance, nature-based solutions that protect coastal ecosystems and infrastructure.
Nov 14, 2023
Oct 27, 2023
The Wolfpack Investor Network (“WIN”) is North Carolina State University’s angel investor group that provides capital and guidance to NC State connected, early-stage companies. WIN has just announced the completion of two investments in Voxel Innovations, Inc. (“Voxel”), a Raleigh based company that machines high-quality metal components using proprietary versions of pulsed electrochemical machining (“PECM”).
Dec 5, 2022
Deep Blue Medical Advances announced today it has received an additional 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its T-Line® Hernia Mesh for the sublay technique in open hernia surgery.
Nov 30, 2022
The Wolfpack Investor Network (WIN), NC State University’s alumni-driven, early-stage investor group, is partnering with Harbright Ventures to enhance WIN member engagement, provide pre- and post-deal investment leadership and increase support for the broader NC State entrepreneurial community.
Mar 29, 2022
Local VCs band together to back Durham company that uses data science to improve outcomes in healthcare and clinical research.
Jan 4, 2022
An award-winning Durham startup that developed a methodology for analyzing climate risk has been acquired by S&P Global, a publicly traded company.
Dec 8, 2021
NC State continues to earn national recognition as one of the nation’s best undergraduate and graduate entrepreneurship programs in the nation by the Princeton Review and Entrepreneur magazine.
Oct 28, 2021
Led by CEO Jon Woodworth, biospatial applies the cutting-edge machine learning and AI technology developed by its executive team of data analytics vets to its unique collection of aggregated EMS data for use cases ranging from Covid-19 contact tracing to early bio-terrorism threat detection.
Oct 26, 2021
Big announcements make for invigorating days at the Spiffy office, and today is no exception. We are thrilled to announce that we have closed our $22 million Series B funding round!